Cyrano Therapeutics
Business Services · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
190 Congress Park Dr Ste 210, Delray Bea...Phone Number
(925) 822-6461Website
www.cyranotherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Cyrano Therapeutics
Cyrano Therapeutics is a private, venture-backed clinical stage regenerative medicine company developing a novel therapy to restore smell and flavor function.Explore more
Cyrano Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cyrano Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cyrano Therapeutics had a recent Job posting/layoffs
Cyrano Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Cyrano Therapeutics is spiking on competitors!
Earning: See what the market has to say on Cyrano Therapeutics recently announced quarterly report
Check if Cyrano Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Cyrano Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Cyrano Therapeutics launches new products
Funding: Get notified immidiatlly once Cyrano Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Cyrano Therapeutics
Compare insights from companies similar to Cyrano Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cyrano Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cyrano Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cyrano Therapeutics.
Cyrano Therapeutics financials insights
Gather financial insights about Cyrano Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$12.8M
2024
Series B
$9M
Cyrano Therapeutics Tech Stack
A closer look at the technologies used by Cyrano Therapeutics
Most Recent Scoops
Executive Move
Executive Moves, Board of Directors
Funding
Funding
Funding
Cyrano Therapeutics News & Media
Cyrano Therapeutics Announces Positive Topline Results from Phase 2 FLAVOR Trial of CYR-064, a Proprietary and Potential First-to-Market Regenerative Therapy for Persistent Smell Loss
Trial met its primary safety and key prespecified secondary efficacy endpoints, supporting advancement into Phase 3 development in 2H 2026 DELRAY BEACH, Fla., Feb. 17, 2026 /PRNewswire/ -- Cyrano Therapeutics, Inc., a clinical-stage regenerative medicine company developing novel...Cyrano Therapeutics Completes Enrollment in Phase 2 FLAVOR Trial of CYR-064 for Post-Viral Smell Loss
Data Expected in Q4 2025 from Study Evaluating the First Potential Therapy for Post-Viral Hyposmia DELRAY BEACH, Fla., April 10, 2025 /PRNewswire/ -- Cyrano Therapeutics, Inc., a clinical-stage regenerative medicine company pioneering the development of treatments for smell loss, today...Cyrano Therapeutics and Resyca Announce Exclusive License Agreement for Soft Mist Nasal Spray Technology for the Treatment of Chemosensory Dysfunction
Soft Mist Nasal Spray Technology Designed to Enhance Drug Deposition in the Olfactory Region, Increasing the Potential for CYR-064's Therapeutic Efficacy DELRAY BEACH, Fla and ENSCHEDE, Netherlands, March 18, 2025 /PRNewswire/ -- Cyrano Therapeutics, a clinical-stage regenerative medicine...KYORIN and Cyrano Therapeutics Enter into an Option Agreement for CYR-064 for the Treatment of Post-Viral Loss of Smell in Japan
Agreement Provides Cyrano Therapeutics with Upfront and Milestone Payments, Plus Royalties from Commercialization of CYR-064 in Japan DELRAY BEACH, Fla., Feb. 18, 2025 /PRNewswire/ -- Cyrano Therapeutics, Inc., a clinical-stage regenerative medicine company pioneering the development of...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cyrano Therapeutics
Sign Up For FreeTo access detailed company insights
Cyrano Therapeutics is a private, venture-backed clinical stage regenerative medicine company developing a novel therapy to restore smell and flavor function.... Read More
